| 57 |
Dong-A ST holds ‘1st Dong-A ST Open Innovation Research Project’ contest |
2017-12-26 |
| 56 |
Dong-A ST hosts series of launch symposiums for Edarbi, a hypertension treatment |
2017-12-21 |
| 55 |
Dong-A ST holds ‘ISO 37001’ Initiation Ceremony for Internal Auditors of the Anti-Bribery Committee |
2017-11-24 |
| 54 |
Dong-A ST holds ‘Declaration Ceremony for CP Reinforcement and ISO 37001 Introduction’ |
2017-11-23 |
| 53 |
Dong-A ST obtained Advisory Committee’ Support for FDA Approval for its Tedizolid |
2014-04-01 |
| 52 |
Dong-A ST begins to export ‘Closerin,’ TB medication, to China |
2014-03-26 |
| 51 |
Dong-A ST selected as primary supplier of anti-tuberculosis agents for the WHO in its global project |
2014-01-07 |
| 50 |
The US FDA accepts the New Drug Application (NDA) for Tedizolid, Dong-A ST’s super-bacteria antibiot |
2014-01-07 |
| 49 |
Dong-A ST launches Zydena 75mg, a daily tablet designed to liberate users from worries over erectile |
2013-12-18 |
| 48 |
Dong-A ST’s new global drug most likely to be approved and marketed soon |
2013-11-06 |
